Clinical trial
A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children
NCT00319670 · Braintree Laboratories, Industry · Completed
Key facts
| NCT number | NCT00319670 |
|---|---|
| Title | A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children |
| Official title | A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children |
| Lead sponsor | Braintree Laboratories, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | MiraLax |
| Enrollment | 25 |
| Start date | Mar 1, 2006 |
| Primary completion | May 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 7, 2013 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: